Eric Schmidt's involvement in AI funding raises questions about the openness and accessibility of research, as concerns grow over potential commercialization. The super alignment team emphasizes their commitment to sharing outcomes for the benefit of humanity, while the recent upheaval within the company highlights the need for safeguards to prevent instability in AI development.
